Baxter International Inc (NYSE: BAX)

Baxter International Inc. provides a broad portfolio of essential healthcare products, including sterile intravenous solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, advanced surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. These products serve hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision.

The company generates revenue primarily through the sale of its healthcare products and related services to healthcare providers and patients. Revenue is derived from the sale of sterile IV solutions, infusion sets, parenteral nutrition, inhaled anesthetics, injectable drugs, surgical sealants, smart beds, monitors, respiratory devices, and drug compounding services. Baxter sells its offerings via a direct sales force and through independent distributors, drug wholesalers, and specialty pharmacy providers in over 100 countries.

The company operates through the following segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.

• Medical Products & Therapies: This segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies, and surgical hemostat, sealant, and adhesion prevention products.

• Healthcare Systems & Technologies: This segment includes sales of connected care solutions and collaboration tools, such as smart bed systems, patient monitoring systems, diagnostic technologies, respiratory health devices, and advanced surgical equipment including operating room integration technologies and precision positioning devices.

• Pharmaceuticals: This segment includes sales of specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services.

Baxter holds a strong position in the global healthcare industry due to its broad and deep product portfolio and extensive international footprint. The company benefits from competitive advantages such as wide-ranging offerings, strong relationships with hospitals and group purchasing organizations, shared manufacturing efficiencies, and technological innovation. While no single competitor matches Baxter across all its businesses, it faces substantial competition in each segment from diverse domestic and international healthcare, medical device, and pharmaceutical firms.

Baxter serves a diverse customer base that includes hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, physicians’ offices, kidney dialysis centers, and patients receiving care at home under physician supervision.